Li et al. identified a novel 5-gene signature (HOXC10, LOC101928747, CYB561D2, RPL36A, and RPS4XP2) as an independent predictor of prognosis in glioma patients who received radiotherapy [48]. The gene discussed is RPS4XP2; the disease is central nervous system cancer.